샘플 요청 목록

 카트 문의
시장보고서
상품코드
1941427

메디컬 라이팅 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Medical Writing Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

메디컬 라이팅 시장 요약

세계의 메디컬 라이팅 시장 규모는 2025년 50억 7,000만 달러로 추정되며, 2033년까지 110억 9,000만 달러에 이를 것으로 예측됩니다.

또한 2026-2033년 연평균 복합 성장률(CAGR) 10.29%를 나타낼 것으로 예측됩니다. 메디컬 라이팅 담당자에 대한 높은 수요는 CRO(의약품 개발 수탁기관)에 대한 아웃소싱 증가, 시장 기업의 R&D 투자 확대, 개발도상국의 임상시험 환경, 새로운 의료기기 규제 등에 기인하고 있습니다.

2024년 7월, 셀레전스는 The Journal of mHealth 저널에서 생성형 AI(GenAI)가 의약품 메디컬 라이팅을 변화시킬 수 있는 가능성을 지적하며, 57%의 조직이 투자를 계획하고 있다고 보고했습니다. 도입 노하우가 문제이지만, 관리된 실험과 파트너십을 통해 효율성 향상, 비용절감, 경쟁력 유지가 가능합니다. 제약회사들은 환자들에게 더 나은 도달을 위해 광고 전략을 조정하고 있습니다. 또한, 소셜 미디어가 고객의 의사결정에 미치는 영향력이 확대됨에 따라 제약 및 생명공학 기업들은 마케팅 전략을 재검토해야 하는 상황에 직면해 있습니다. 건강/웰니스 관련 블로그의 견조한 성장은 과학 문서 작성에 대한 수요 증가에 기여할 것으로 예측됩니다. 2025년 9월 'Health Promotion International'지에 게재된 논문에서는 의료 글쓰기 산업의 규모를 분석한 결과, 영어권 의학 문헌에 기여하는 의료 교육 및 커뮤니케이션 기업(MECC)이 1,148개에 달하는 것으로 나타났습니다. 이 연구에 따르면, 2만 건 이상의 과학 논문이 감사의 글에 의학 논문 작성 지원을 언급하고 있으며, 그 중 50% 이상이 단 10개의 제약 회사가 후원하는 것으로 밝혀져 업계의 규모와 자금 기반이 집중되어 있음을 알 수 있습니다.

규제 당국은 제품 개발의 모든 단계에서 엄격한 조사 방법을 요구하고 있으며, 이는 승인 절차를 복잡하게 만들고 향후 몇 년 동안 시장 성장을 가속하고 있습니다. 보험사는 상환 정책 수립을 위해 의약품 정보를 필요로 합니다. 그 결과, 제약사들은 업계 표준을 준수하는 데 어려움을 겪고 있습니다. 2024년 6월, 미국 의학작가협회(AMWA) 블로그에 게재된 기사는 의료 작문 직종의 확장을 지적했습니다. 미국 노동통계국의 예측에 따르면, 2032년까지 기술 문서 작성 직종은 7% 증가할 것으로 예상되며, 업계 데이터에 따르면 개발 중인 의약품이 약 8,000개, 2000년 이후 FDA 승인 건수가 약 900건에 달한다고 합니다. 이를 종합하면, 임상, 규제, 상업 활동 전반에 걸쳐 의료용 라이터에 대한 지속적인 수요가 있음을 알 수 있습니다.

시장에서는 새로운 트렌드로 여러 전략적 제휴 관계가 생겨나고 있습니다. 각 CRO가 단일 기능을 제공하고, 여러 서비스 제공업체가 유지되는 형태입니다. R&D 투자 증가에 따라 임상시험 건수도 증가하는 추세입니다. 2024년 9월, 유럽 내과학 저널은 AI와 대규모 언어 모델이 과학적인 의학 글쓰기를 빠르게 변화시키고 있으며, 문헌 검토, 번역, 통계 분석을 지원하고 있다는 점을 강조했습니다.

자주 묻는 질문

  • 메디컬 라이팅 시장 규모는 어떻게 예측되나요?
  • 메디컬 라이팅 시장의 성장 요인은 무엇인가요?
  • 의약품 메디컬 라이팅에 대한 AI의 영향은 무엇인가요?
  • 의료 작문 직종의 전망은 어떻게 되나요?
  • 메디컬 라이팅 시장에서의 규제 당국의 역할은 무엇인가요?
  • 메디컬 라이팅 시장의 새로운 트렌드는 무엇인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 메디컬 라이팅 시장 변수, 동향·범위

제4장 메디컬 라이팅 시장 부문 분석 : 유형별, 2021년-2033년

제5장 메디컬 라이팅 시장 부문 분석 : 용도별, 2021년-2033년

제6장 메디컬 라이팅 시장 부문 분석 : 최종 용도별, 2021년-2033년

제7장 메디컬 라이팅 시장 부문 분석 : 지역별, 2021년-2033년

제8장 경쟁 구도

LSH 26.03.11

Medical Writing Market Summary

The global medical writing market size was estimated at USD 5.07 billion in 2025 and is projected to reach USD 11.09 billion by 2033, growing at a CAGR of 10.29% from 2026 to 2033. The high demand for medical writers can be attributed to a rise in CRO outsourcing, increased R&D investments by market players, a favorable environment for clinical study in developing countries, and new medical device regulations.

In July 2024, Celegence highlighted in The Journal of mHealth that Generative AI (GenAI) could transform pharmaceutical medical writing, with 57% of organizations planning investment. While deployment knowledge is a challenge, controlled experiments and partnerships can boost efficiency, cut costs, and keep companies competitive. Pharmaceutical companies have adapted their advertising strategies to improve patient outreach. In addition, the growing influence of social media on customers' decisions has compelled pharmaceutical and biotechnology companies to reconsider their marketing strategies. The robust growth of health and wellness-related blogs is expected to boost the demand for scientific writing. In September 2025, an article published in Health Promotion International analyzed the scale of the medical writing industry, identifying 1,148 medical education and communication companies (MECCs) contributing to English-language medical literature. The study found that over 20,000 scientific papers acknowledged medical writing support, with more than 50% sponsored by just ten pharmaceutical companies, highlighting the industry's size and concentrated funding base.

Regulatory authorities want a thorough methodology for all phases of product development, which complicates the approval process boosting the market growth in the coming years. Insurance companies want drug information to establish reimbursement policies. As a result, pharmaceutical companies are finding it difficult to adhere to industry standards. In June 2024, an article published by the American Medical Writers Association (AMWA) Blog highlighted the expanding medical writing profession, citing U.S. Bureau of Labor Statistics projections of 7% growth in technical writing roles by 2032 and industry data showing nearly 8,000 medicines in development and about 900 FDA approvals since 2000, collectively pointing to sustained demand for medical writers across clinical, regulatory, and commercial activities.

There is a new trend in the market of multiple strategic relationships, wherein each CRO provides a single function and multiple service providers are maintained. Clinical trials are increasing in number as a result of increased R&D investments. In September 2024, the European Journal of Internal Medicine highlighted that AI and large language models are rapidly transforming scientific medical writing, aiding literature review, translation, and statistical analysis.

Global Medical Writing Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global medical writing market report based on type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical Writing
  • Regulatory Writing
  • Scientific Writing
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Medical Journalism
  • Medical Education
  • Medico Marketing
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Medical Device/Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations & Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Spain
    • Italy
    • France
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Writing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing volume of clinical trials and regulatory submissions
      • 3.2.1.2. Rising complexity of global regulatory requirements
      • 3.2.1.3. Growing outsourcing of medical writing by pharmaceutical and biotechnology companies
      • 3.2.1.4. Expansion of pharmacovigilance and post-marketing surveillance activities
      • 3.2.1.5. Adoption of AI-enabled tools to improve medical writing efficiency
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High dependence on skilled and experienced medical writing professionals
      • 3.2.2.2. Data quality, consistency, and compliance challenges in outsourced documentation
  • 3.3. Medical Writing: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Technology Landscape
  • 3.5. Case Studies

Chapter 4. Medical Writing Market Segment Analysis, By Type, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Medical Writing Market, by Type, 2021 to 2033
  • 4.5. Clinical Writing
    • 4.5.1. Clinical writing market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Regulatory writing
    • 4.6.1. Regulatory writing market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Scientific Writing
    • 4.7.1. Scientific writing market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Medical Writing Market Segment Analysis, By Application, 2021 - 2033 (USD Million) (Procedure Volume, In Thousand)

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Medical Writing Market, by Application, 2021 to 2033
  • 5.5. Medical Journalism
    • 5.5.1. Medical journalism market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Medical Education
    • 5.6.1. Medical education market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Medical Marketing
    • 5.7.1. Medical marketing market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Medical Writing Market Segment Analysis, By End Use, 2021-2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2025 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Medical Writing Market, by end use, 2021 to 2033
  • 6.5. Medical Device/Pharma & Biotech Companies
    • 6.5.1. Medical device/pharma & biotech companies market estimates and forecasts, 2021 to 2033 (USD million)
  • 6.6. Contract Research Organizations & Others
    • 6.6.1. Contract research organizations & others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Medical Writing Market Segment Analysis, By Region, By Type By Application, By End Use, 2021 - 2033 (USD Million)

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Medical Writing Market Share by Region, 2025 & 2033:
  • 7.5. North America
    • 7.5.1. North America Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. U.S. Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory Framework & Reimbursement Scenario
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Canada Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory Framework & Reimbursement Scenario
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico Medical Writing Market, 2021 - 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. UK Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Germany Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. France Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Italy Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Spain Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Norway Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Sweden Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.9.3. Competitive Scenario
      • 7.6.9.4. Denmark Medical Writing Market, 2021 - 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Japan Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. China Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. India Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Australia Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. South Korea Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.6.3. Competitive Scenario
      • 7.7.6.4. Thailand Medical Writing Market, 2021 - 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory Framework & Reimbursement Scenario
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Brazil Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Argentina Medical Writing Market, 2021 - 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory Framework & Reimbursement Scenario
      • 7.9.1.3. Competitive Scenario
      • 7.9.1.4. South Africa Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. Saudi Arabia Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory Framework & Reimbursement Scenario
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. UAE Medical Writing Market, 2021 - 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory Framework & Reimbursement Scenario
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. Kuwait Medical Writing Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Level Market Share Analysis, 2024/2025 (%)
  • 8.4. Company Profiles
    • 8.4.1. Parexel International Corporation
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Premier Research
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Freyr
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. IQVIA Holdings Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Certara Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Quanticate
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Soterius, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Alimentiv
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Syneos Health
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. EVERSANA
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제